Maximum effectiveness, minimal side effects, least-possible damage to healthy tissue. Scientists have long pursued cancer treatment offering one or more of these benefits, and a researcher at the University of Tennessee at Chattanooga is now among them. Michael Danquah is researching a highly precise form of treatment delivery—at the nanoscale, molecular level—to fight leukemia. Danquah researched vaccine production as a chemical engineering doctoral student and today is director of…
